Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,165.00
+3.00 (0.26%)
Jul 22, 2026, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 20.15 billion as of July 22, 2026. Its market cap has decreased by -45.50% in one year.
Market Cap
20.15B
Enterprise Value
19.13B
Revenue
2.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,165.00
ChartMarket Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 20.15B, a decrease of -77.67%. That is a compound annual growth rate of -52.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 20.15B | -29.86% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 92.22B |
| MedPacto | 89.63B |
| Amicogen | 80.18B |
| iNtRON Biotechnology | 76.51B |
| ENCell | 66.95B |
| CG Invites | 65.05B |
| Prestige BioPharma | 62.62B |
| ORIENT BIO | 53.47B |